1. Home
  2. LINE vs GRFS Comparison

LINE vs GRFS Comparison

Compare LINE & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LINE
  • GRFS
  • Stock Information
  • Founded
  • LINE 2012
  • GRFS 1940
  • Country
  • LINE United States
  • GRFS Spain
  • Employees
  • LINE N/A
  • GRFS N/A
  • Industry
  • LINE
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LINE
  • GRFS Health Care
  • Exchange
  • LINE NYSE
  • GRFS Nasdaq
  • Market Cap
  • LINE 9.8B
  • GRFS 6.2B
  • IPO Year
  • LINE 2024
  • GRFS 2006
  • Fundamental
  • Price
  • LINE $43.55
  • GRFS $10.85
  • Analyst Decision
  • LINE Buy
  • GRFS Hold
  • Analyst Count
  • LINE 18
  • GRFS 1
  • Target Price
  • LINE $66.11
  • GRFS $10.30
  • AVG Volume (30 Days)
  • LINE 971.9K
  • GRFS 1.3M
  • Earning Date
  • LINE 08-06-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • LINE 4.87%
  • GRFS N/A
  • EPS Growth
  • LINE N/A
  • GRFS N/A
  • EPS
  • LINE N/A
  • GRFS N/A
  • Revenue
  • LINE $5,302,000,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • LINE $3.65
  • GRFS $5.40
  • Revenue Next Year
  • LINE $5.00
  • GRFS $6.74
  • P/E Ratio
  • LINE N/A
  • GRFS $26.99
  • Revenue Growth
  • LINE N/A
  • GRFS 10.76
  • 52 Week Low
  • LINE $40.49
  • GRFS $6.19
  • 52 Week High
  • LINE $89.85
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • LINE N/A
  • GRFS 76.81
  • Support Level
  • LINE N/A
  • GRFS $9.53
  • Resistance Level
  • LINE N/A
  • GRFS $10.17
  • Average True Range (ATR)
  • LINE 0.00
  • GRFS 0.30
  • MACD
  • LINE 0.00
  • GRFS 0.05
  • Stochastic Oscillator
  • LINE 0.00
  • GRFS 81.99

About LINE LINEAGE INC

Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: